We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-3.38%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$43.6M
AUM Growth
-$446M
(-91%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-1,013.48%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
580
New
77
Increased
4
Reduced
27
Closed
472
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.24M |
| 2 |
TSMC
TSM
|
+$1.13M |
| 3 |
NuScale Power
SMR
|
+$1.11M |
| 4 |
Trade Desk
TTD
|
+$1.02M |
| 5 |
Microchip Technology
MCHP
|
+$910K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$5.39M |
| 2 |
Accenture
ACN
|
+$5.35M |
| 3 |
CRWV
CoreWeave
CRWV
|
+$4.97M |
| 4 |
Robinhood
HOOD
|
+$4.87M |
| 5 |
Expedia Group
EXPE
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.63% |
| 2 | Healthcare | 13.02% |
| 3 | Communication Services | 12.94% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Albemarle
ALB
$13.5B
| – | – |
-6,150
| Closed | -$499K |
|
127
Alkermes
ALKS
$8.82B
| – | – |
-8,074
| Closed | -$242K |
|
128
Ally Financial
ALLY
$13.1B
| – | – |
-9,898
| Closed | -$388K |
|
129
Ambarella
AMBA
$2.99B
| – | – |
-11,400
| Closed | -$941K |
|
130
Advanced Micro Devices
AMD
$851B
| – | – |
-2,300
| Closed | -$372K |
|
131
American Homes 4 Rent
AMH
$12B
| – | – |
-18,900
| Closed | -$628K |
|
132
Amplitude
AMPL
$1.07B
| – | – |
-51,500
| Closed | -$552K |
|
133
Arista Networks
ANET
$219B
| – | – |
-4,300
| Closed | -$627K |
|
134
ANI Pharmaceuticals
ANIP
$1.77B
| – | – |
-11,500
| Closed | -$1.05M |
|
135
Aon
AON
$77.3B
| – | – |
-5,093
| Closed | -$1.82M |
|
136
Air Products & Chemicals
APD
$66.3B
| – | – |
-11,526
| Closed | -$3.14M |
|
137
Applied Digital
APLD
$7.77B
| – | – |
-15,600
| Closed | -$358K |
|
|
APLS
138
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-25,500
| Closed | -$577K |
|
139
Appian
APPN
$1.74B
| – | – |
-21,692
| Closed | -$663K |
|
140
Digital Turbine
APPS
$1.02B
| – | – |
-26,100
| Closed | -$167K |
|
141
Aptiv
APTV
$12B
| – | – |
-5,656
| Closed | -$488K |
|
142
Arcos Dorados Holdings
ARCO
$1.73B
| – | – |
-27,979
| Closed | -$189K |
|
143
argenx
ARGX
$57.4B
| – | – |
-2,920
| Closed | -$2.15M |
|
144
Arlo Technologies
ARLO
$1.4B
| – | – |
-36,700
| Closed | -$622K |
|
145
Arcutis Biotherapeutics
ARQT
$3.42B
| – | – |
-24,000
| Closed | -$452K |
|
146
Asana
ASAN
$1.58B
| – | – |
-67,360
| Closed | -$900K |
|
|
EFOR
147
Everforth Inc
EFOR
$845M
| – | – |
-9,400
| Closed | -$445K |
|
148
AerSale
ASLE
$292M
| – | – |
-14,523
| Closed | -$119K |
|
149
Aurora
AUR
$11.7B
| – | – |
-26,000
| Closed | -$140K |
|
150
Aveanna Healthcare
AVAH
$2.06B
| – | – |
-30,400
| Closed | -$270K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Bayesian Capital Management held 580 positions worth $43.6M, down 91% from $490M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bayesian Capital Management withdrew a net $442M in Q4 2025, closing 472 positions and reducing 27 holdings. Its most notable exit was Boston Scientific, an estimated $5.39M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Bayesian Capital Management opened a new position in JPMorgan Chase worth $1.29M.
- Bayesian Capital Management's largest Q4 2025 buy was JPMorgan Chase: 4,000 shares worth $1.29M.
- Bayesian Capital Management added most to TSMC in Q4 2025, an estimated $1.13M increase.
- Bayesian Capital Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $4.54M.
- Bayesian Capital Management fully exited Boston Scientific in Q4 2025, selling an estimated $5.39M.
- Bayesian Capital Management's ten largest holdings make up 28% of its $43.6M portfolio in Q4 2025.
- Bayesian Capital Management opened 77 new positions and closed 472 in Q4 2025.
- Bayesian Capital Management's portfolio value fell 91% quarter-over-quarter to $43.6M.
Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.